A detailed history of Balyasny Asset Management LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Balyasny Asset Management LLC holds 97,000 shares of JNJ stock, worth $14.1 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
97,000
Previous 5,410 1692.98%
Holding current value
$14.1 Million
Previous $790,000 1889.75%
% of portfolio
0.03%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$145.48 - $167.38 $15.4 Million - $17.7 Million
105,722 Added 1954.2%
111,132 $18 Million
Q2 2024

Aug 14, 2024

SELL
$144.38 - $157.78 $3.81 Million - $4.17 Million
-26,422 Reduced 83.0%
5,410 $790,000
Q1 2024

May 13, 2024

BUY
$155.22 - $162.74 $1.35 Million - $1.41 Million
8,691 Added 37.56%
31,832 $5.04 Million
Q4 2023

Feb 14, 2024

SELL
$145.6 - $158.88 $24.4 Million - $26.6 Million
-167,542 Reduced 87.86%
23,141 $3.63 Million
Q3 2023

Nov 14, 2023

BUY
$155.75 - $174.48 $28.1 Million - $31.4 Million
180,173 Added 1714.3%
190,683 $29.7 Million
Q2 2023

Aug 14, 2023

SELL
$154.35 - $166.11 $9.78 Million - $10.5 Million
-63,381 Reduced 85.78%
10,510 $1.74 Million
Q1 2023

May 15, 2023

BUY
$151.05 - $180.26 $11.1 Million - $13.3 Million
73,769 Added 60466.39%
73,891 $11.5 Million
Q4 2022

Feb 14, 2023

SELL
$160.2 - $179.79 $1.53 Million - $1.72 Million
-9,577 Reduced 98.74%
122 $21,000
Q3 2022

Nov 14, 2022

BUY
$161.33 - $179.52 $1.56 Million - $1.74 Million
9,699 New
9,699 $1.58 Million
Q1 2022

May 16, 2022

BUY
$158.14 - $179.59 $36 Million - $40.8 Million
227,359 New
227,359 $40.3 Million
Q4 2021

Feb 14, 2022

SELL
$155.93 - $173.01 $91.5 Million - $102 Million
-586,748 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$161.5 - $179.47 $39 Million - $43.3 Million
241,466 Added 69.93%
586,748 $94.8 Million
Q2 2021

Aug 16, 2021

BUY
$159.48 - $171.07 $23.3 Million - $25 Million
146,059 Added 73.31%
345,282 $56.9 Million
Q1 2021

May 17, 2021

SELL
$153.07 - $170.48 $5.66 Million - $6.31 Million
-37,000 Reduced 15.66%
199,223 $32.7 Million
Q4 2020

Feb 16, 2021

BUY
$137.11 - $157.38 $9.66 Million - $11.1 Million
70,450 Added 42.5%
236,223 $37.2 Million
Q3 2020

Nov 16, 2020

SELL
$140.38 - $153.83 $3.11 Million - $3.4 Million
-22,128 Reduced 11.78%
165,773 $24.7 Million
Q2 2020

Aug 14, 2020

BUY
$128.81 - $155.51 $1.58 Million - $1.91 Million
12,275 Added 6.99%
187,901 $26.4 Million
Q4 2019

Feb 14, 2020

SELL
$127.5 - $146.44 $37.6 Million - $43.1 Million
-294,544 Reduced 62.65%
175,626 $25.6 Million
Q3 2019

Nov 14, 2019

BUY
$126.95 - $142.14 $45.6 Million - $51 Million
359,150 Added 323.5%
470,170 $60.8 Million
Q2 2019

Aug 14, 2019

BUY
$131.15 - $144.24 $11.6 Million - $12.8 Million
88,657 Added 396.45%
111,020 $15.5 Million
Q1 2019

May 15, 2019

BUY
$125.72 - $139.79 $1.23 Million - $1.36 Million
9,744 Added 77.22%
22,363 $3.13 Million
Q2 2018

Aug 14, 2018

BUY
$119.4 - $131.76 $1.51 Million - $1.66 Million
12,619 New
12,619 $1.53 Million
Q1 2018

May 15, 2018

SELL
$125.1 - $148.14 $13.5 Million - $16 Million
-107,858 Closed
0 $0
Q4 2017

Feb 14, 2018

SELL
$131.22 - $143.62 $43 Million - $47 Million
-327,399 Reduced 75.22%
107,858 $15.1 Million
Q3 2017

Nov 14, 2017

BUY
$129.47 - $135.38 $56.4 Million - $58.9 Million
435,257
435,257 $56.6 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $381B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.